OncoSil Medical Limited (ASX:OSL)
Australia · Delayed Price · Currency is AUD 0.5200
-0.0300 (-5.45%)
Mar 18, 2026, 4:15 PM AEST
OncoSil Medical Market Cap
OncoSil Medical has a market cap or net worth of 13.81 million as of March 18, 2026. Its market cap has decreased by -49.91% in one year.
Market Cap
13.81M
Enterprise Value
11.00M
Revenue
3.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.52
Market Cap Chart
Since August 15, 2005, OncoSil Medical's market cap has increased from 7.29M to 13.81M, an increase of 89.38%. That is a compound annual growth rate of 3.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 12.99M | -29.12% |
| Dec 31, 2025 | 18.33M | -33.55% |
| Dec 31, 2024 | 27.58M | 55.21% |
| Dec 28, 2023 | 17.77M | -60.28% |
| Dec 30, 2022 | 44.74M | 25.48% |
| Dec 31, 2021 | 35.65M | -63.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Micro-X | 48.65M |
| HeraMED | 46.88M |
| Nova Eye Medical | 39.17M |
| CleanSpace Holdings | 37.09M |
| ImpediMed | 32.62M |
| Atomo Diagnostics | 30.79M |
| CurveBeam AI | 27.71M |
| Control Bionics | 23.89M |